Work

Tailoring Antiplatelet Adherence

Year: 2026

Type: article

Abstract: Background The use of P2Y 12 inhibitor is highly variable, and administration is frequently confounded by inconsistent documentation that heightens risks for mismanagement, particularly following transitions of care. Project Rationale Insufficient documentation clearly defining the indication and therapeutic duration for antiplatelet agents carries potential risks for bleeding and/or ischemia. This was observed in patients who were veterans and was felt to represent a modifiable quality gap. Project Summary A 2-phase quality improvement initiative at the New Mexico Veterans Affairs Health Care System reviewed documentation among 1,100 veterans prescribed a P2Y 12 inhibitor. In a randomly selected sample of 135 patients, 27% lacked documentation clearly defining therapeutic duration, and 8.4% continued P2Y 12 inhibitor beyond the intended stop date. A structured electronic health record document and automated reminders were developed using a Plan-Do-Study-Act framework to address these concerns. Take-Home Message Structured electronic health record documentation with automated reminders can improve antiplatelet stewardship and safety.

Source: JACC Case Reports

DOI: 10.1016/j.jaccas.2026.109457

Authors: Rudra Pratap Singh, Breandan Kelly, Seerat Sachdeva, Stephanie Rosenberg, Harmon R. Cannon, Linda Macdonald

Institutions: University of New Mexico, University of New Mexico Health Sciences Center

Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $850